Healio Hematology & Oncology News: Interviewed Dr. Berenson on his perspective on Abstract 1 & Abstract 2.
Questions: Reaction to results -- anything surprising? Most important take home message or clinical implication.
HemOnc today - Multiple Myeloma regimens significantly less effective in real-world treatment settings
PERSPECTIVE (read article) James R. Berenson, MD.
Can JAK Inhibition Help Overcome Lenalidomide Resistance in Myeloma? Early-phase experience with ruxolitinib suggests potential role in relapsed/refractory disease
Early-phase experience with ruxolitinib suggests potential role in relapsed/refractory disease.Following is a transcript of his remarks
Does Smoldering Myeloma Treatment Need To Be Aggressive?
Smoldering myeloma happens when changes in the blood are caught early in a blood test and is a precursor to multiple myeloma. What is it like living with smoldering myeloma and how aggressively should you be monitored and treated?